Main Banner Desktop
hybio

Hybio Pharmaceutical Co., Ltd

Unverified company Unverified company
map-marker

自从 2020

map-marker

中国

  • Imagem 1

Curing Diabetics 204656-20-2 Peptide Liraglutide API


单价:

未通知

FOB价:

未通知

最低采购数量:

2 其他类型

付款方式:

信用证

电汇

首选港:

未通知

参考:

未通知


产品描述

Function:

Medical uses
Liraglutide is a once-daily injectable derivative of the human incretin (metabolic hormone) glucagon-like peptide-1 (GLP-1), for the treatment of type 2 diabetes or obesity.

Type 2 diabetes
Liraglutide improves control of blood glucose. It reduces meal-related hyperglycemia (for 24 hours after administration) by increasing insulin secretion (only) when required by increasing glucose levels, delaying gastric emptying, and suppressing prandial glucagon secretion.

It acts in a glucose-dependent manner, meaning it will stimulate insulin secretion only when blood glucose levels are higher than normal, preventing "overshoot". Consequently, it shows negligible risk of hypoglycemia.
It has the potential for inhibiting apoptosis and stimulating regeneration of beta cells (seen in animal studies).
It decreases appetite and inhibits body weight gain, as shown in a head-to-head study versus glimepiride.
It lowers blood triglyceride levels.

  • Liraglutide
  • DIABETICS
  • BLOOD SUGAR
  • obesity
  • INSULIN

产能:

500000

运输时间表:

立即

Incoterms:

CIF - Cost, Insurance and Freight

EXW - Ex Works

FOB - Free on Board

包装明细:

PE bag+ foil bag+aluminum tin+carton


更多关于
Hybio Pharmaceutical Co., Ltd

icone de usuario

500-1000

员工

sales icon

1

销售额(美元)

icone de exportar

40%

% 出口销售额

1998

Year

成立年份


业务类型
  • Industry / Manufacturer
  • Business Service

关键词
  • 多肽原料药
  • 制剂
  • 利拉鲁肽
  • 索马鲁肽
  • 阿托西班
  • 特利加压素
  • 加尼瑞克
  • 格拉替雷
  • 依替巴肽
  • 去氨加压素
  • Ver Mais

联系方式和位置
  • icone de usuario Andrew Li
  • icone de telefone +86 xxxxxxxx
  • map-marker 深圳 / | 中国

提出您的要求

提出您的要求

icon-checked-none

icon-checked-none